Home/Reports/DD Evolution Round — 2026-06-08

DD Evolution Round — 2026-06-08

2026-06-08 19:16 · 11.6 KB

Type: Deep Evolve

Date: June 8, 2026

Stocks Updated: SoftBank Group (9984.T), Keyence (6861.T), JCU Corporation (4975.T)


Summary

Three stocks evolved today covering Sovereign AI, Robotics/FA, and AI GPU Supply Chain themes. Key developments: SoftBank Group posted Japan's largest ever corporate profit (¥5T from OpenAI gains) but faces new liquidity risks; Keyence confirmed 5th consecutive record year with Q4 acceleration; JCU Corporation posted record FY2026 on Ibiden's ¥500B capex commitment.


9984.T — SoftBank Group Corp | UPGRADED (LOW → MEDIUM)

Theme: Sovereign AI | Conviction: MEDIUM (was LOW)

Thesis Update

SoftBank Group is Japan's AI infrastructure architect at a ~30% NAV discount. FY2025 (year ending March 2026) produced Japan's highest-ever corporate net income: ¥5.00T (+334% YoY) — driven by OpenAI fair-value gain of ¥6.73T as OpenAI's valuation reached $852B. The underlying AI engine, ARM Holdings (87.1% stake), delivered $4.92B revenue (+23% YoY) with a new AGI CPU and Compute Subsystems platform launched March 2026. Stargate Japan (Sakai City, Osaka) is concrete: 150MW / 100,000 GPUs at a former Sharp LCD factory (~¥1T investment), with operations beginning 2026.

Upgraded rationale: ARM performing beyond expectations. OpenAI stake 2.8x in value ($64.6B invested → $79.6B fair value). Stargate Japan advancing from plan to construction. Japan AI Foundation Model Development launched (Apr 12 2026, with NEC, ¥1T/5yr government support). EU €75B AI infrastructure commitment added geographic diversification.

Key Metrics (as of June 8, 2026)

MetricValueSourceDate
PE (trailing)6.7xcompaniesmarketcap2026-06-08
Forward PE34.2xstockanalysis2026-06-08
P/B4.61xstockanalysis (ARM revaluation)2026-06-08
Market Cap~¥42Tcompaniesmarketcap2026-06-08
NAV (official)¥40.1TSBG IR May 20262026-05-13
NAV Discount~30%vs Morningstar FV ¥9,7892026-06-08
FY2025 NI¥5.002TSBG IR2026-05-13
ARM Revenue FY2026$4.92B +23%ARM SEC 6-K2026-05
OpenAI FV$79.6B (~13% stake)SBG IR2026-05-13
Standalone Debt¥16.3TCNBC2026-06-04

Supply Chain (5 confirmed links)

1. OpenAI / Stargate LLC (confirmed) — $64.6B invested; 40% JV partner; Sakai City 150MW DC; EU €75B; SB Energy $1B JV

2. ARM Holdings (confirmed) — 87.1% stake; $4.92B rev +23%; AGI CPU launched March 2026

3. Japan AI Foundation Model Development (confirmed) — April 12 2026 launch with NEC; sovereign 1T-parameter model

4. EU AI Infrastructure (confirmed) — €75B commitment announced

5. SB Energy (confirmed) — OpenAI + SBG co-invested $1B; building Stargate data centers

Key Dates

  • June 24, 2026 — SoftBank Group 46th AGM (dividend, LTV disclosure, AI articles)
  • August 2026 — Q1 FY2026 results
  • H2 2026 — OpenAI IPO potential (could crystallize $130B+ at $1T valuation)

Risk Flags

⚠ S&P NEGATIVE OUTLOOK (March 2026) — S&P revised SBG outlook to Negative citing "deteriorating asset liquidity." SBG acknowledged it may breach its self-imposed 25% LTV guardrail "temporarily." This is a material credit risk.

⚠ PEAK EARNINGS (paper) — MINOR — ¥5T NI is 90%+ paper gains (OpenAI mark-to-market). If OpenAI corrects from $852B valuation, NI reverses. Underlying operating cash generation is far smaller.

⚠ CONCENTRATION — ARM (40% assets) + OpenAI (26% assets) = 66% in 2 assets. ARM at 66x 2026E earnings is expensive.

⚠ DEBT — ¥16.3T standalone debt; $40B bridge loan taken March 2026. Guardrail: monitor LTV ratio quarterly.

Inversion

Thesis breaks if: (1) ARM market cap drops >25% from peak; (2) OpenAI faces regulatory action or competitor displaces GPT; (3) D/E rises above 250% without new revenue; (4) NAV discount widens past 50% indicating loss of market confidence.


6861.T — Keyence Corporation | HOLD (HIGH conviction maintained)

Theme: Robotics, AI Vision, FA Automation | Conviction: HIGH

Thesis Update

5th consecutive year of record results. FY2025 (April 2025–March 2026) confirmed structural dominance:

  • Revenue ¥1,169.3B (+10.4%), Operating Profit ¥595.8B (+8.4%), Net Income ¥445.2B (+11.7%)
  • Operating margin 51.0% — slight dip from 51.9% but structural 50%+ intact
  • Q4 FY2025 acceleration: +17.9% revenue, +25.4% NI — ending year with momentum
  • Asia +16.7% (China recovery confirmed), Americas +13.3% (CHIPS Act demand real), Japan +4.6%
  • VS-G series AI vision system launched June 2026 (25MP, AI-hybrid, IP67 rated)
  • Market cap now ¥20.41T (was ¥15.22T in April — stock +34%)
  • No guidance issued (company policy); IBES consensus: FY2026 NI ¥484.2B (+8.8%)

Key Metrics (as of June 8, 2026)

MetricValueSourceDate
PE (TTM)~40xcompaniesmarketcap2026-06-08
Forward PE38xIBES consensus2026-06-08
P/B~6.1x (est.)inferred from mktcap2026-06-08
Market Cap¥20.41Tcompaniesmarketcap2026-06-05
OP Margin FY202551.0%Keyence IR2026-04-24
NI FY2025¥445.2B +11.7%Keyence IR2026-04-24
EPS FY2025¥1,836 (record)Keyence IR2026-04-24
Dividend¥550/shareKeyence IR2026-04-24
Net Cash¥1.33Thistorical2026-04

Key Dates

  • June 30, 2026 — Semiannual portfolio rebalance
  • July 27, 2026 — Q1 FY2027 results (April–June 2026) — CRITICAL: watch margin and China trend
  • December 2026 — Q2 FY2027 results

Risk Flags

⚠ PEAK EARNINGS RISK (AMBER) — 5th consecutive record year. Margin dipped 51.9%→51.0%. IBES consensus implies deceleration to +8.8% NI growth. PE ~40x well above sector average 15-20x. Stock above DCF fair value per SimplyWallSt. Not at peak in absolute terms, but valuation premium leaves no margin of safety.

⚠ COMPETITOR RECOVERY — Cognex Q1 2026 revenue +24% YoY (vs Keyence Americas +13.3%). Cognex recovering faster in North America vision market. Monitor quarterly.

Guardrail override (PB): PB ~6.1x elevated for FA equipment. Override: Keyence's 51% OP margin and zero-debt ¥1.33T net cash justify structural premium.

Inversion

Thesis breaks if: (1) Operating margin falls below 48% for 2+ consecutive quarters; (2) Americas growth stalls as Cognex recovers market share; (3) PE compression from 40x to 25x means -37% even with earnings growth.


4975.T — JCU Corporation | UPGRADED (MEDIUM → MEDIUM-HIGH)

Theme: AI/GPU Supply Chain | Conviction: MEDIUM-HIGH (was MEDIUM)

Thesis Update

Near-monopoly via-filling copper plating chemistry (CU-BRITE brand) posted record FY2026 results (year ended March 2026): Revenue ¥29.67B (+4.6%), NI ¥9.07B (+21% YoY), operating margin 41.0% — highest in our entire universe. Key structural demand driver: Ibiden committed ¥500B in ABF substrate capacity expansion (Feb 2026), adding Gifu and Ono plants for 60-70% capacity increase. Ibiden CEO: demand "robust, likely to last at least through next year." JCU's complexity multiplier: as AI chips get more layers and finer pitch, each chip requires more plating chemistry per unit. New TIPHARES brand for next-gen packaging. Forward dividend ¥180/share (+89% vs FY2026 ¥95) signals management's confidence.

Upgraded rationale: Record profits + Ibiden ¥500B capex = structural multi-year demand confirmed. Market cap updated ¥154B→¥180.71B.

Key Metrics (as of June 8, 2026)

MetricValueSourceDate
PE (TTM)19.9xStockopedia2026-05-29
Forward PEN/AFY2027 NI guidance flat-to-down
P/B3.01xStockAnalysis2026-06-08
ROE17.2%StockAnalysis2026-06-08
OP Margin FY202641.0%JCU IR2026-05-12
Market Cap¥180.71Bcompaniesmarketcap2026-05-29
Revenue FY2026¥29.67B +4.6%JCU IR2026-05-12
NI FY2026¥9.07B +21%JCU IR2026-05-12
Dividend FY2026¥95/shareJCU IR2026-05-12
Dividend FY2027 guide¥180/share (+89%)JCU IR2026-05-12

Supply Chain (4 links)

1. Ibiden (4062.T) (confirmed) — ¥500B capex commitment Feb 2026; CU-BRITE chemistry for FC-BGA/ABF substrates; Gifu/Ono plants 60-70% capacity increase

2. Shinko Electric/Resonac (confirmed) — IC packaging substrates for Intel/AMD

3. AT&S, Samsung Electro-Mechanics (probable) — analyst coverage indirect exposure

4. NVIDIA (indirect via Ibiden/Shinko) (inferred) — JCU chemistry in every Ibiden substrate used in H100/B100/GB200 GPUs

Key Dates

  • August 2026 — Q1 FY2027 results — CRITICAL: confirm whether FY2027 NI dip is structural or investment-driven
  • June 30, 2026 — Semiannual rebalance (consider weight 5%→7% if Aug confirms MEDIUM-HIGH)

Risk Flags

⚠ FY2027 NI DIP — WATCH — FY2027 guidance shows revenue +12.6% but NI declining. Unexplained. Possibly: investment ramp (TIPHARES product line), FX headwinds, or higher tax rate. Cannot determine structural vs tactical without Q1 data. Do not act on this flag until August 2026 earnings.

Guardrail override (PB cyclical): P/B 3.01 for specialty chemicals flagged. Override: 41% OP margin is extraordinary for chemicals sector (industry average ~10-15%). This is a structural monopoly supplier, not a cyclical chemicals company. Premium warranted.

Inversion

Thesis breaks if: (1) Q1 FY2027 NI shows structural margin compression (not investment); (2) Ibiden cancels/delays ¥500B capex program; (3) MKS/Atotech or Uyemura wins key design test at Ibiden/Shinko; (4) Alternative via-filling chemistry achieves equivalent quality for next-gen packaging specs.


Risk Flags Summary

TickerFlagSeverityAction
9984.TS&P Negative Outlook, ¥16.3T debt, LTV guardrailHIGHMonitor AGM Jun 24 LTV disclosure
9984.TNI ¥5T = 90% paper OpenAI gainsMEDIUMUse Forward PE 34.2x not trailing 6.7x
6861.TPE ~40x above sector; stock above DCFMEDIUMQ1 Jul 27 — any miss = multiple compression
6861.TMargin dip 51.9%→51.0%AMBERWatch quarterly trend
4975.TFY2027 NI flat-to-down despite revenue growthAMBERConfirm at Q1 Aug 2026

Methodology

  • All metrics sourced from Tier 1-2 sources (company IR filings, J-Quants, StockAnalysis, CompaniesMarketCap)
  • Every supply chain link verified against independent sources with URLs and dates
  • Anti-pattern checks (peak earnings, capacity expansion, concept stock) explicitly cleared or flagged
  • Valuation guardrails checked per data/config/valuation_guardrails.json
  • Full trace: data/research_traces/2026-06-08_evolve.jsonl

Sources


*Research conducted 2026-06-08. Not investment advice. All figures in JPY unless noted.*